InsiderTrades

Form 4 for NEO NEOGENOMICS INC

Accepted 2024-05-14 00:00:00 ET · period of report 2024-05-11 · accession 0001077183-24-000075 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-05-14 2024-05-11 NEO Smith Christopher M CEO M - OptEx $0.00 +96.1K 650.3K +17% $0
D 2024-05-14 2024-05-11 NEO Smith Christopher M CEO F - Tax $14.86 -18.9K 631.4K -3% -$281.0K
D 2024-05-14 2024-05-11 NEO Smith Christopher M CEO M - OptEx $0.00 -48.1K 96.1K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-11 M A 48,063 $0.00 679,432 D — —
2 Common Common Stock 2024-05-11 M A 48,063 $0.00 650,282 D — — (F1) Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
3 Common Common Stock 2024-05-11 F D 18,913 $14.86 631,369 D — — (F2) Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
4 Derivative Restricted Stock Unit 2024-05-11 M D 48,063 $0.00 96,127 D $0.00 · — to — 48,063 Common Stock (F3) On May 11, 2023, Mr. Smith was granted 144,190 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date. (F4) Once vested, the shares of common stock are not subject to expiration.